At a glance
ClinicalIndex Comparison RecordN/ACompleted· 781 enrolled
Drug / intervention
cyclosporine ophthalmic emulsion 0.05%, artificial tearsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
In Brief
An observational study evaluating cyclosporine ophthalmic emulsion 0.05%, artificial tears for Keratoconjunctivitis Sicca. Completed, enrolled 781 participants across 1 site.
Detailed Summary
This study will evaluate the efficacy of cyclosporine ophthalmic solution vs. other non-prescription treatments in patients with dry eye disease. Patient and physician assessments completed at baseline, at each follow-up visit (follow-up visits are variable as per physician discretion) and at final follow-up visit.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsKeratoconjunctivitis Sicca
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2004
Primary CompletionAug 2006
First PostedJul 2008
Study CompletionAug 2008
TodayJul 2026
First PostedJul 17, 2008
Enrollment StartSep 1, 2004
Primary CompletionAug 1, 2006
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 18.0 years ago
Interventions
cyclosporine ophthalmic emulsion 0.05%, artificial tearsdrug
one drop, twice a day in each eye